Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides.
Publication
, Journal Article
Papalas, JA; Sebastian, S; Wang, E
Published in: Leuk Lymphoma
May 2011
Duke Scholars
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
May 2011
Volume
52
Issue
5
Start / End Page
905 / 907
Location
United States
Related Subject Headings
- Mycosis Fungoides
- Male
- Lymphoma, T-Cell
- Immunology
- Humans
- Genotype
- Gene Rearrangement
- Cell Transformation, Neoplastic
- CD4 Antigens
- Antibodies, Monoclonal
Citation
APA
Chicago
ICMJE
MLA
NLM
Papalas, J. A., Sebastian, S., & Wang, E. (2011). Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides. Leuk Lymphoma, 52(5), 905–907. https://doi.org/10.3109/10428194.2010.551157
Papalas, John A., Siby Sebastian, and Endi Wang. “Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides.” Leuk Lymphoma 52, no. 5 (May 2011): 905–7. https://doi.org/10.3109/10428194.2010.551157.
Papalas JA, Sebastian S, Wang E. Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides. Leuk Lymphoma. 2011 May;52(5):905–7.
Papalas, John A., et al. “Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides.” Leuk Lymphoma, vol. 52, no. 5, May 2011, pp. 905–07. Pubmed, doi:10.3109/10428194.2010.551157.
Papalas JA, Sebastian S, Wang E. Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides. Leuk Lymphoma. 2011 May;52(5):905–907.
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
May 2011
Volume
52
Issue
5
Start / End Page
905 / 907
Location
United States
Related Subject Headings
- Mycosis Fungoides
- Male
- Lymphoma, T-Cell
- Immunology
- Humans
- Genotype
- Gene Rearrangement
- Cell Transformation, Neoplastic
- CD4 Antigens
- Antibodies, Monoclonal